The page is the record's research on the issuer — no analyst, no rating, no view. # IMPACT BIOMEDICAL INC. (NYSE: IBO) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is IMPACT BIOMEDICAL INC., listed on the NYSE under ticker IBO. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Nevada. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 30 filings in the twelve months to 2026-11-08, across 19 filing days. The median gap between filing days is 10.0 days. The latest filing is dated 2026-11-05, 3 days before the record date, and is of type directors_dealings. The exchange median is 6.0 days for cadence and 4.0 days for latency, with a median of 64.0 filings across 3256 issuers. The sector median is 6.0 days for cadence and 4.0 days for latency, with a median of 63.0 filings across 526 issuers. The issuer's cadence gap of 10.0 days is above both medians, and its 30 filings are below the exchange median of 64.0 and below the sector median of 63.0. ## Auditor The auditor of record is GRASSI & CO., CPAs, P.C., located in Jericho, New York. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag shows listed, not halted. ## Orderability The outcome is not determinable under rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, version r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found for the issuer. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed filings for the issuer in the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://data.sec.gov/submissions/CIK0001834105.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/IBO (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1834105/000149315226009711/form10-k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/IBO (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/IBO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp